FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to neurology, and can be used to treat an individual having a super-refractory status epilepticus (SRSE). For this, an effective amount of allopregnanolone is administered to the mentioned individual, while simultaneously with the mentioned administration, the individual is under the influence of general anesthesia.
EFFECT: invention provides for treatment for a patient with SRSE.
35 cl, 2 dwg, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF TREATMENT OF EPILEPSY OR STATUS EPILEPTICUS | 2013 |
|
RU2824132C2 |
| NEUROACTIVE STEROID FORMULATIONS AND METHODS OF TREATING CNS DISORDERS | 2013 |
|
RU2681835C2 |
| NEUROACTIVE STEROID SOLUTIONS AND METHODS FOR ADMINISTRATION | 2016 |
|
RU2803464C2 |
| NEUROACTIVE STEROIDS, COMPOSITIONS AND METHODS OF USING THEM | 2015 |
|
RU2731000C2 |
| NEUROACTIVE STEROIDS, COMPOSITIONS AND APPLICATIONS THEREOF | 2017 |
|
RU2766155C2 |
| ANAESTHETIC COMPOSITION | 2011 |
|
RU2574022C2 |
| COMPOSITIONS CONTAINING ACETAMINOPHENE AND CYCLODEXTRIN SULFAOKYL ETHER | 2017 |
|
RU2772384C2 |
| COMPOSITION CONTAINING CYCLODEXTRIN AND BUSULFAN | 2018 |
|
RU2787621C2 |
| INHALATION COMPOSITION CONTAINING SULFOALKYL ETHER | 2004 |
|
RU2388462C2 |
| COMPLEX OF RAS-FARNESYLTRANSFERASE INHIBITOR, COMPOSITION OF RAS-FARNESYLT RANSFERASE INHIBITOR, PHARMACEUTICAL COMPOSITION | 1999 |
|
RU2230062C2 |
